C. H. Polman - Concepedia

Author

C. H. Polman

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

C H Polman, C. H. Polman, C.H. Polman, CH Polman, K. Schimrigk

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University Medical Center University Hospital and Clinics

About

C. H. Polman is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	372
2	Health Sciences	1	1	146
3	Public Health	1	1	121
4	Social Sciences	1	1	39
5	Allergy	1	1	43

C. H. Polman

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes Ludwig Kappos, C. H. Polman, Mark S. Freedman, Neurology	2006	672
POSTWITHDRAWAL REBOUND INCREASE IN T2 LESIONAL ACTIVITY IN NATALIZUMAB-TREATED MS PATIENTS M.M. Vellinga, Jonas A. Castelijns, Frederik Barkhof, Neurology Neurological DisorderImmunologyNeurological ProgressMultimodalityBrain Lesion	2007	146
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis M.A.A. van Walderveen, M. W. Tas, Frederik Barkhof, Neurology Magnetic Resonance EvaluationMr Disease ActivityNeurological DisorderGynecologyMaternal Health	1994	121
Serum homocysteine levels in relation to clinical progression in multiple sclerosis Charlotte E. Teunissen, Joep Killestein, Jolijn J Kragt, Journal of Neurology Neurosurgery & Psychiatry	2008	60
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components? LVAE Bosma, JJ Kragt, Luís Brieva, Multiple Sclerosis Journal	2010	52
Infusion-related hypersensitivity reactions during natalizumab treatment J. Theodore Phillips, Paul O’Connor, Eva Havrdová, Neurology ImmunohematologyAllergy MedicineImmunologyAllergenSkin Allergy	2006	43
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis Theodora A. M. Siepman, A. Cecile J.W. Janssens, Ina M. Koning, Journal of Neurology Multiple Sclerosis DiagnosisNeurological FunctioningPsychiatryNeurological DisorderMedicine	2008	39
Vitality, perceived social support and disease activity determine the performance of social roles in recently diagnosed multiple sclerosis: A longitudinal analysis V. de Groot, Heleen Beckerman, JW Twisk, Acta Dermato Venereologica	2008	27
Efficacy of subcutaneous interferon -1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes Nicola De Stefano, Giancarlo Comi, Ludwig Kappos, Journal of Neurology Neurosurgery & Psychiatry	2013	25
Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2 J. J. Heimans, John Wagstaff, W. O. Schreuder, Surgical Neurology OphthalmologyLeptomeningeal CarcinomatosisImmunologyContinuous Intraventricular InfusionImmunotherapy	1991	23

Page 1